Hans Louis Jos de Winter
Keine laufenden Positionen mehr
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Jan Delcour | M | - |
Université Catholique de Louvain
| 33 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Willem Broekaert | M | - |
Université Catholique de Louvain
| 15 Jahre |
| Frederic de Sauvage | M | - |
Université Catholique de Louvain
| 8 Jahre |
| Johan van den Bossche | M | - |
Silicos SA
 Silicos SA Pharmaceuticals: MajorHealth Technology Silicos, founded in June 2005, is a chemo-informatics-based biotechnology company empowering proprietary multi-target virtual screening technologies for the discovery of novel and high-quality lead compounds for the treatment of a large variety of diseases, such as cancer, infectious diseases, central nervous system and immunodeficiency diseases. Silicos' proprietary virtual screening technology is based on a unique concept called Spectrophores™, which are descriptors representing all possible three-dimensional molecular properties involved in the binding of a drug to its receptor. Cosmos™ is Silicos' platform for the de novo design of new small molecules optimized towards one or multiple targets. | - |
| Roland Pirmez | M | 64 |
Université Catholique de Louvain
| 6 Jahre |
| Bart de Moor | M | 63 |
Silicos SA
Silicos SA Pharmaceuticals: MajorHealth Technology Silicos, founded in June 2005, is a chemo-informatics-based biotechnology company empowering proprietary multi-target virtual screening technologies for the discovery of novel and high-quality lead compounds for the treatment of a large variety of diseases, such as cancer, infectious diseases, central nervous system and immunodeficiency diseases. Silicos' proprietary virtual screening technology is based on a unique concept called Spectrophores™, which are descriptors representing all possible three-dimensional molecular properties involved in the binding of a drug to its receptor. Cosmos™ is Silicos' platform for the de novo design of new small molecules optimized towards one or multiple targets. | - |
| Gert Adam Irma Thijs | M | - |
Silicos SA
Silicos SA Pharmaceuticals: MajorHealth Technology Silicos, founded in June 2005, is a chemo-informatics-based biotechnology company empowering proprietary multi-target virtual screening technologies for the discovery of novel and high-quality lead compounds for the treatment of a large variety of diseases, such as cancer, infectious diseases, central nervous system and immunodeficiency diseases. Silicos' proprietary virtual screening technology is based on a unique concept called Spectrophores™, which are descriptors representing all possible three-dimensional molecular properties involved in the binding of a drug to its receptor. Cosmos™ is Silicos' platform for the de novo design of new small molecules optimized towards one or multiple targets. | 7 Jahre |
| Wilfried van Langenaeker | M | - |
Silicos SA
Silicos SA Pharmaceuticals: MajorHealth Technology Silicos, founded in June 2005, is a chemo-informatics-based biotechnology company empowering proprietary multi-target virtual screening technologies for the discovery of novel and high-quality lead compounds for the treatment of a large variety of diseases, such as cancer, infectious diseases, central nervous system and immunodeficiency diseases. Silicos' proprietary virtual screening technology is based on a unique concept called Spectrophores™, which are descriptors representing all possible three-dimensional molecular properties involved in the binding of a drug to its receptor. Cosmos™ is Silicos' platform for the de novo design of new small molecules optimized towards one or multiple targets. | 7 Jahre |
| Zeger Debyser | M | - |
Université Catholique de Louvain
| 7 Jahre |
| Christine Morris | F | - |
Université Catholique de Louvain
| 6 Jahre |
| Lieven Larmuseau | M | 62 |
Université Catholique de Louvain
| 2 Jahre |
| Luc Gellens | M | 68 |
Université Catholique de Louvain
| 8 Jahre |
| Armando J. Arrieta M. | M | - |
Université Catholique de Louvain
| 5 Jahre |
| Peter Paul Godelieve Kloeck | M | 60 |
Université Catholique de Louvain
| 6 Jahre |
| Marcos Stefan Kulka Kuperman | M | - |
Université Catholique de Louvain
| 5 Jahre |
| Marcin Lukaszewicz | M | - |
Université Catholique de Louvain
| 5 Jahre |
| Marcin Ziemowit Lukaszewicz | M | 57 |
Université Catholique de Louvain
| 5 Jahre |
| Peter van Overschee | M | - |
Université Catholique de Louvain
| 5 Jahre |
| Urbain Vandeurzen | M | 68 |
Université Catholique de Louvain
| 8 Jahre |
| Johan Cardoen | M | 65 |
Université Catholique de Louvain
| 6 Jahre |
| Willem Frans Alfons van Twembeke | M | 59 |
Université Catholique de Louvain
| 8 Jahre |
| Bernard Thuysbaert | M | - |
Université Catholique de Louvain
| 4 Jahre |
| Pascale Schobbens-Vin | F | 59 |
Université Catholique de Louvain
| 3 Jahre |
| Onno W. Verstegen | M | 61 |
Université Catholique de Louvain
| 2 Jahre |
| Hugues Wynants | M | - |
Université Catholique de Louvain
| 5 Jahre |
| Geert van Haver | M | 67 |
Université Catholique de Louvain
| 2 Jahre |
| Alexis Bernard | M | 50 |
Université Catholique de Louvain
| 5 Jahre |
| Bert Vermeire | M | - |
Université Catholique de Louvain
| 1 Jahre |
| Erik Vanderhaegen | M | - |
Université Catholique de Louvain
| 3 Jahre |
| Geert Voet | M | - |
Université Catholique de Louvain
| 2 Jahre |
| Eddy Hartung | M | 72 |
Université Catholique de Louvain
| 4 Jahre |
| Juan-Francisco Defalque | M | 59 |
Université Catholique de Louvain
| 1 Jahre |
| Xavier Denis | M | 52 |
Université Catholique de Louvain
| 4 Jahre |
| Emmanuel Herve Gerard Fiévet | M | 55 |
Université Catholique de Louvain
| 4 Jahre |
| Bai Chun Xiao | M | 76 |
Université Catholique de Louvain
| 2 Jahre |
| Pierre Focant | M | 56 |
Université Catholique de Louvain
| 4 Jahre |
| Matt Roswell | M | - |
Université Catholique de Louvain
| 1 Jahre |
| Philippe Carron | M | 64 |
Université Catholique de Louvain
| 1 Jahre |
| Marc Ernaelsteen | M | - |
Université Catholique de Louvain
| 4 Jahre |
| Marc Van Den Neste | M | - |
Université Catholique de Louvain
| 5 Jahre |
| Isabelle Peeters | F | - |
Université Catholique de Louvain
| 5 Jahre |
| Maria Leonor Modesto | F | 66 |
Université Catholique de Louvain
| 3 Jahre |
| Benoît Champluvier | M | - |
Université Catholique de Louvain
| 4 Jahre |
| José Miguel B. Schorcht da Silva Pessanha | M | 63 |
Université Catholique de Louvain
| 1 Jahre |
| Jean-Marc Legrand | M | - |
Université Catholique de Louvain
| 3 Jahre |
| Rafael Vicente Correa Delgado | M | 61 |
Université Catholique de Louvain
| 1 Jahre |
| Philippe Lamberts | M | 61 |
Université Catholique de Louvain
| 4 Jahre |
| Piet van Riet | M | 62 |
Université Catholique de Louvain
| 1 Jahre |
| Sylvie Duvieusart-Marquant | F | 58 |
Université Catholique de Louvain
| 3 Jahre |
| Emanuela Bonadiman | F | 61 |
Université Catholique de Louvain
| 4 Jahre |
| Vincent Vliebergh | M | - |
Université Catholique de Louvain
| 4 Jahre |
| Nicolas Logé | M | 58 |
Université Catholique de Louvain
| 4 Jahre |
| Daniel Falque | M | 60 |
Université Catholique de Louvain
| 1 Jahre |
| Louvrier Pierre Michel | M | 51 |
Université Catholique de Louvain
| 3 Jahre |
| Leen Deley | F | 52 |
Université Catholique de Louvain
| 4 Jahre |
| Paul Deleu | M | 64 |
Université Catholique de Louvain
| 4 Jahre |
| François-Myriam-J. Derbaix | M | - |
Université Catholique de Louvain
| 5 Jahre |
| Benoît Timmermans | M | 63 |
Université Catholique de Louvain
| 3 Jahre |
| Tiziano Brianza | M | 68 |
Université Catholique de Louvain
| 3 Jahre |
| Jean Martin | M | 65 |
Université Catholique de Louvain
| 4 Jahre |
| Gil Beyen | M | 62 |
Université Catholique de Louvain
| 1 Jahre |
| Mathieu Francois Pierre Pasture | M | - |
Université Catholique de Louvain
| 4 Jahre |
| Marc Mommaerts | M | - |
Silicos SA
Silicos SA Pharmaceuticals: MajorHealth Technology Silicos, founded in June 2005, is a chemo-informatics-based biotechnology company empowering proprietary multi-target virtual screening technologies for the discovery of novel and high-quality lead compounds for the treatment of a large variety of diseases, such as cancer, infectious diseases, central nervous system and immunodeficiency diseases. Silicos' proprietary virtual screening technology is based on a unique concept called Spectrophores™, which are descriptors representing all possible three-dimensional molecular properties involved in the binding of a drug to its receptor. Cosmos™ is Silicos' platform for the de novo design of new small molecules optimized towards one or multiple targets. | - |
| Guy Mannaerts | M | - |
Silicos SA
Silicos SA Pharmaceuticals: MajorHealth Technology Silicos, founded in June 2005, is a chemo-informatics-based biotechnology company empowering proprietary multi-target virtual screening technologies for the discovery of novel and high-quality lead compounds for the treatment of a large variety of diseases, such as cancer, infectious diseases, central nervous system and immunodeficiency diseases. Silicos' proprietary virtual screening technology is based on a unique concept called Spectrophores™, which are descriptors representing all possible three-dimensional molecular properties involved in the binding of a drug to its receptor. Cosmos™ is Silicos' platform for the de novo design of new small molecules optimized towards one or multiple targets. | - |
| Luc Dehaspe | M | - |
Université Catholique de Louvain
| 1 Jahre |
| Juan Pablo Spoerer Hurtado | M | 54 |
Université Catholique de Louvain
| 4 Jahre |
| Armando Arrieta | M | - |
Université Catholique de Louvain
| 2 Jahre |
| Danny van D'huynslager | M | - |
Université Catholique de Louvain
| 4 Jahre |
| Patrick Lemmens | M | 68 |
Université Catholique de Louvain
| 3 Jahre |
| Marc Josz | M | 66 |
Université Catholique de Louvain
| 4 Jahre |
| Marc Nolet de Brauwere | M | - |
Université Catholique de Louvain
| 4 Jahre |
| Eric Merkel-Sobotta | M | 60 |
Université Catholique de Louvain
| 3 Jahre |
| Daniel Hugues Jules Gauthier | M | 67 |
Université Catholique de Louvain
| 1 Jahre |
| Pierre de Muelenaere | M | 65 |
Université Catholique de Louvain
| 3 Jahre |
| Pierre Simard | M | 59 |
Université Catholique de Louvain
| 2 Jahre |
| Jan Gesquière | M | 63 |
Université Catholique de Louvain
| 4 Jahre |
| Dirk de Backer | M | 53 |
Université Catholique de Louvain
| 5 Jahre |
| Vincent de Dorlodot | M | 59 |
Université Catholique de Louvain
| 3 Jahre |
| Eduardo de Salles Bartolomeo | M | 60 |
Université Catholique de Louvain
| 2 Jahre |
| Paul Embrechts | M | 71 |
Université Catholique de Louvain
| 8 Jahre |
| Ricardo Prada Silvy | M | - |
Université Catholique de Louvain
| 3 Jahre |
| Jean Eylenbosch | M | 65 |
Université Catholique de Louvain
| 3 Jahre |
| Li Liu | M | 69 |
Université Catholique de Louvain
| 2 Jahre |
| Peter Raeymaeckers | M | - |
Université Catholique de Louvain
| 4 Jahre |
| Benoît Godts | M | 68 |
Université Catholique de Louvain
| 3 Jahre |
| Léon Baron Bekaert | M | 66 |
Université Catholique de Louvain
| 4 Jahre |
| Karel Lannoo | M | - |
Université Catholique de Louvain
| 1 Jahre |
| Ghassan Hanna Sulaiman Tarazi | M | 60 |
Université Catholique de Louvain
| 2 Jahre |
| Eric Conrads | M | - |
Université Catholique de Louvain
| 4 Jahre |
| Annick van Overstraeten | F | 58 |
Université Catholique de Louvain
| 1 Jahre |
| Bertrand Désirand | M | - |
Université Catholique de Louvain
| 4 Jahre |
| Eric Tancré | M | 64 |
Université Catholique de Louvain
| 4 Jahre |
| Grégoire Dallemagne | M | 51 |
Université Catholique de Louvain
| 4 Jahre |
| Joris Coppye | M | 58 |
Université Catholique de Louvain
| 4 Jahre |
| Philippe Maeckelberghe | M | 64 |
Université Catholique de Louvain
| 2 Jahre |
| Etienne Robert Christian Ferain | M | - |
Université Catholique de Louvain
| 3 Jahre |
| Carlo Bernardus Ghislain Groffils | M | - |
Université Catholique de Louvain
| 4 Jahre |
| Dieter Penninckx | M | - |
Université Catholique de Louvain
| 5 Jahre |
| Frédéric Adam | M | - |
Université Catholique de Louvain
| 4 Jahre |
| Stanislas Kervyn | M | - |
Université Catholique de Louvain
| 5 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Belgien | 100 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Hans Louis Jos de Winter
- Persönliches Netzwerk
